Literature DB >> 9350646

Reversibility of experimental secondary hyperparathyroidism.

E Lewin1, W Wang, K Olgaard.   

Abstract

Chronic uremia is associated with secondary hyperparathyroidism (HPT). The purpose of the present investigation was to study the reversibility of secondary HPT after reversal of uremia by an isogenic kidney transplantation in the rat. Secondary HPT was induced in two models: Model A comprised 5/6 nephrectomized rats kept on a standard diet (N = 12; PTH 210 +/- 43 pg/ml; plasma urea 24 +/- 2 mmol/liter; and normal control rats, N = 12; PTH 45 +/- 5 pg/ml; plasma urea 6 +/- 0.2 mmol/liter); and Model B comprised 5/6 nephrectomized rats kept on a high phosphorus diet (N = 12; PTH 769 +/- 157 pg/ml; plasma urea 18 +/- 2 mmol/liter). The parathyroid function was examined by measuring the secretory response of PTH to an acute induction of hypo- and hypercalcemia. Acute hypocalcemia in the hyperphosphatemic uremic rats did not significantly increase serum PTH levels (N = 6, delta Ca2+ -0.56 mmol/liter; maximal PTH 1045 +/- 164 pg/ml; basal PTH 690 +/- 134 pg/ml; NS). During hypercalcemia the PTH levels were significantly higher than in the normal controls (N = 6; minimal PTH 24 +/- 5 pg/ml vs. normal controls 5 +/- 0.2 pg/ml, P < 0.05). After 20 weeks of uremia, the uremia was reversed by the isogenic kidney transplantation. One week after reversal of the uremia the PTH levels became normal in both models A and B (28 +/- 6 and 63 +/- 16 pg/ml, respectively) and the kidney transplanted rats from model B had a normal secretory response of PTH to both hypo- and hypercalcemia. To study whether both parathyroid cell hypertrophy and hyperplasia could be down-regulated, 8 uremic glands (N = 9) or 20 normal glands (N = 6) were implanted into one normal rat. Within two weeks the rats regained normocalcemia and PTH levels remained normal from the third day after the increase of glandular mass. The 20 gland rats all had normal PTH suppressibility in response to calcium (minimal PTH 5 +/- 0.3 pg/ml). In conclusion, experimental severe secondary hyperparathyroidism is reversible very quickly after the reversal of uremia. Hyperphosphatemia in uremia is important for the non-suppressibility of the parathyroid glands to calcium. In non-uremic rats even severe parathyroid hyperplasia can be controlled, resulting in normal plasma PTH and Ca2+ levels and in a normal response to hypercalcemia. Thus, the minimal PTH secretion obtained during the induction of hypercalcemia is not an expression of the parathyroid mass.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350646     DOI: 10.1038/ki.1997.448

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Application of total parathyroidectomy with auto-transplantation for uremia secondary hyperparathyroidism treatment.

Authors:  Ying Jing; Hanhui Zhao; Yanming Ge; Fengyu Jia; Qingqing He; Suxia Wang; Jianzhong Meng
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Absence of response to human parathyroid hormone in athymic mice grafted with human parathyroid adenoma, hyperplasia or parathyroid cells maintained in culture.

Authors:  B G Hory; M C Roussanne; S Rostand; A Bourdeau; T B Drüeke; J Gogusev
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

3.  Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing.

Authors:  Jakob L Rukov; Eva Gravesen; Maria L Mace; Jacob Hofman-Bang; Jeppe Vinther; Claus B Andersen; Ewa Lewin; Klaus Olgaard
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-06

4.  Factors associated with calcium requirements after parathyroidectomy in chronic kidney disease patients.

Authors:  Yue Ding; Hongying Wang; Qiang Zou; Yiting Jin; Zijing Zhang; Junwen Huang
Journal:  Int Urol Nephrol       Date:  2017-12-01       Impact factor: 2.370

5.  Chronic Kidney Disease-Induced Vascular Calcification Impairs Bone Metabolism.

Authors:  Maria L Mace; Eva Gravesen; Anders Nordholm; Soeren Egstrand; Marya Morevati; Carsten Nielsen; Andreas Kjaer; Geert Behets; Patrick D'Haese; Klaus Olgaard; Ewa Lewin
Journal:  J Bone Miner Res       Date:  2020-12-10       Impact factor: 6.741

Review 6.  Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism.

Authors:  Zeli Xiang; Ming Wang; Changxiu Miao; Die Jin; Hongyue Wang
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

7.  Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism.

Authors:  Jacob Hofman-Bang; Eva Gravesen; Klaus Olgaard; Ewa Lewin
Journal:  Int J Nephrol       Date:  2012-10-10

8.  Parathyroid hormone-producing cells exist in adipose tissues surrounding the parathyroid glands in hemodialysis patients with secondary hyperparathyroidism.

Authors:  Takatoshi Kakuta; Kaichiro Sawada; Genta Kanai; Ryoko Tatsumi; Takayo Miyakogawa; Mari Ishida; Raima Nakazawa; Masafumi Fukagawa
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

Review 9.  New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease-Mineral and Bone Disorder.

Authors:  Maria L Mace; Søren Egstrand; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Metabolites       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.